NZ314730A - Use of dideoxycytosine derivatives in the treatment of viral infection - Google Patents

Use of dideoxycytosine derivatives in the treatment of viral infection

Info

Publication number
NZ314730A
NZ314730A NZ314730A NZ31473093A NZ314730A NZ 314730 A NZ314730 A NZ 314730A NZ 314730 A NZ314730 A NZ 314730A NZ 31473093 A NZ31473093 A NZ 31473093A NZ 314730 A NZ314730 A NZ 314730A
Authority
NZ
New Zealand
Prior art keywords
dideoxycytosine
derivatives
treatment
viral infection
viral
Prior art date
Application number
NZ314730A
Inventor
Tarek Mansour
Allan H L Tse
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929226927A external-priority patent/GB9226927D0/en
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of NZ314730A publication Critical patent/NZ314730A/en

Links

NZ314730A 1992-12-24 1993-12-22 Use of dideoxycytosine derivatives in the treatment of viral infection NZ314730A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226927A GB9226927D0 (en) 1992-12-24 1992-12-24 Dideoxy nucleoside analogues
NZ259487A NZ259487A (en) 1992-12-24 1993-12-22 Dideoxycytidine nucleoside analogues and their use in the treatment of viral infections

Publications (1)

Publication Number Publication Date
NZ314730A true NZ314730A (en) 1998-10-28

Family

ID=26302222

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ314730A NZ314730A (en) 1992-12-24 1993-12-22 Use of dideoxycytosine derivatives in the treatment of viral infection

Country Status (1)

Country Link
NZ (1) NZ314730A (en)

Similar Documents

Publication Publication Date Title
GB9223552D0 (en) Improvements in or relating to the treatment of effluents
GB8906891D0 (en) Improvements in or relating to the inactivation of infectious agents
AU7428491A (en) Treatment of fabrics
AU7428291A (en) Treatment of fabrics
AU626005B1 (en) Treatment of endometriosis
GB9304746D0 (en) Treatment of viral infections
GB9201920D0 (en) Novel treatment i
HU9301871D0 (en) Phenyl-propione and cinnamonic acid derivatives holding imidazolyle substitutent
AU4812393A (en) Use of rapamycin in the treatment of aids
AU7428391A (en) Treatment of fabrics
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB9419692D0 (en) Treatment of herpes infections
PL317876A1 (en) Combined treatment of hiv infections
GB9217124D0 (en) Medical treatment
AU4319393A (en) Use of indolocarbazols in aids treatment
GB9222012D0 (en) Improvements relating to the treatment of haemophilia
NZ314730A (en) Use of dideoxycytosine derivatives in the treatment of viral infection
EP0655919A4 (en) Treatment of human viral infections.
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
AU4096889A (en) The use of lactam derivatives in the treatment of depression
ZA941471B (en) Treatment of viral infections
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
IE880770L (en) Treatment of viral infections
GB9422923D0 (en) Treatment of viral infections
AU5960894A (en) Treatment of viral infections

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: SHIRE CANADA INC., CA

Free format text: OLD OWNER(S): SHIRE BIOCHEM INC.

EXPY Patent expired